Skip to Main Content

Paper Details

Induction of senescence-associated secretory phenotype underlies the therapeutic efficacy of PRC2 inhibition in cancer.
Cell Death Dis
15
2022
Author NameAffiliation
En LiChina Novartis Institutes for BioMedical Research
Liye ZhangShanghaiTech University
Qingyi WeiShanghaiTech University
  • 1 - 3

Datasets

Release 1.2